Dr Suresh Kumar

Biocon’s Psoriasis Drug Itolizumab Receives DCGI Nod for Emergency Use in Covid-19

Bengaluru: Biocon, the global biopharmaceuticals company, has said that it has received the Drugs Controller General of India’s (DCGI) approval…